"The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of dalbavancin 500 mg (Xydalba, Durata Therapeutics) for acute bacterial skin and skin structure infections (ABSSSI) in ad"...
DOSAGE AND ADMINISTRATION
WESTCORT CREAM (hydrocortisone valerate cream) should be applied to the affected area as a thin film two or three times daily depending on the severity of the condition.
As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary. WESTCORT CREAM (hydrocortisone valerate cream) should not be used with occlusive dressings unless directed by a physician. WESTCORT CREAM (hydrocortisone valerate cream) should not be applied in the diaper area if the patient requires diapers or plastic pants as these garments may constitute occlusive dressing.
Westcort® (hydrocortisone valerate cream) CREAM, 0.2%, is supplied in the following tube sizes:
15 g NDC 0072-8100-15: NSN 6505-01-093-9901
45 g NDC 0072-8100-45: NSN 6505-01-083-9395
60 g NDC 0072-8100-60: NSN 6505-01-121-0118
Store between 20° - 25°C (68° - 77°F); excursions permitted between 15° and 30°C
Westwood Squibb Pharmaceuticals, Inc. Princeton, NJ, USA 08543. A Bristol-Myers Squibb Company. Revised 10/2001. FDA Rev date: 3/24/2003This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 1/13/2009
Additional Westcort Cream Information
Westcort Cream - User Reviews
Westcort Cream User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.